CIRM's Next Six Years: Stem Cell Agency Re-examines Its Priorities
The California stem cell agency is taking a fresh look at its strategic plan as it drives more aggressively to develop therapies that can actually be used in the clinic. The re-examination is likely to have an impact on business and academic researchers alike.
The first public session is in Los Angeles today. Tomorrow the 29 members of the CIRM board of…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.